About the journal
Cancer Gene Therapy is a journal published by Springer Nature in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,490 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1476-5500 · 0929-1903
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 4,490 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/cgt/
Index listings
- MEDLINE · 1994-01-01
- PUBMED · 2006-01-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,490 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 205 days received→accepted — computed from PubMed (n=94)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2996
Last recorded publication year
2026
h-index
111
i10-index
2136
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 98%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9432230
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Virus-based gene therapy research
- Virus-based gene therapy research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
Show all subjects (50)
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- RNA modifications and cancer
- RNA modifications and cancer
- Viral Infectious Diseases and Gene Expression in Insects
- Viral Infectious Diseases and Gene Expression in Insects
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Circular RNAs in diseases
- Circular RNAs in diseases
- Herpesvirus Infections and Treatments
- Herpesvirus Infections and Treatments
- Cancer-related Molecular Pathways
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer, Hypoxia, and Metabolism
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
- Cancer Immunotherapy and Biomarkers
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer Immunotherapy and Biomarkers
- RNA Research and Splicing
- RNA Research and Splicing
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Animal Virus Infections Studies
- Animal Virus Infections Studies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- interferon and immune responses
- Cancer-related gene regulation
- Cancer-related gene regulation
- interferon and immune responses
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ